Published on March 20, 2019
Multiple Sclerosis (MS) Among Canadians
11 Canadians are diagnosed with MS every day. This makes up to 4,015 Canadians every year. MS is an autoimmune disease that effects the central nervous system disabling neurological function of young adults. Symptom includes blurred or double vision, hearing impairment, facial’s pain, tremors, reduced sense of taste and smell, etc.
According to research conducted by University of British Columbia and Vancouver Coastal Health, people who receive a beta interferon medication for at least six months to treat MS tend to survive longer than patients who had not taken it before, which leads to a 32 percent lower mortality risk. This potentially could encourage patients with MS to adhere to the prescribed dosing schedule.